Clear cell renal cell carcinoma (RCC) is the most common malignant renal tumor in adults, while chromophobe RCC (CRCC) is the third most common. Any subtypes of RCC can undergo sarcomatoid differentiation, but heterologous differentiation in sarcomatoid area is very rare in RCC. Here a 61-year male is presented with hematuria and palpable mass. Clinicoradiologically, RCC was considered and left radical nephrectomy was performed. A well-circumscribed renal mass located in the upper pole of the left kidney with variegation and extensive areas of bony hard calcification noted, was reported as CRCC with sarcomatoid differentiation containing heterologous component. CRCC subtype has good prognosis but show dismal prognosis when associated with sarcomatous differentiation. We found 11 cases of sarcomatoid CRCC containing heterologous elements reported in indexed English literature. CRCC must be differentiated from Conventional RCC and Oncocytoma. The extensive sampling of the tumor is needed. We report a very rare case of CRCC with sarcomatoid differentiation containing heterologous elements.
Introduction
Recently Renal cell cancer (RCC) is the commonest renal tumor in adults, while it accounts for approximately 3% of all adult malignancies, and is the 12th most common cancer in the world. Classifying RCC based on combination of morphology, molecular and genetic features, clear cell RCC is the commonest (70-90%), which follows by papillary RCC (10-15%) and then chromophobe RCC (CRCC) (3-5%) (1) . CRCC accounts for approximately 5%of surgically removed renal epithelial tumors. Common presentation of RCC is triad of pain, flank mass and hematuria. Sarcomatoid differentiation that can be seen in any subtypes of RCC and CRCC is the third most common subtype associated with sarcomatoid differentiation (2) . CRCC subtype has good prognosis but shows dismal prognosis when associated with sarcomatous differentiation (3). Herein, we report a rare case of CRCC with sarcomatoid differentiation containing heterologous component.
Case Report
A 61-year old male referred to the urology clinic with a palpable mass in the lower left abdomen and hematuria.
A contrast-enhanced CT scan revealed a heterogeneous peripherally enhanced tumor with a central hypovascular area ( Figures 1 and 2) ; clinicoradiologically RCC was suspected and left radical nephrectomy was performed. Grossly, a well-circumscribed solid, beige tumor measuring 7 x 6 x 7cm, located in the upper pole of the left kidney with variegated areas where extensive bony hard calcification were noted ( Figure 3 ). Sections showed a biphasic tumor, having epithelial tumor cells arranged in lobules, sheets and vague nodular pattern separated by fibrovascular septa, which were histomorphologically in favor of CRCC. Large proportion of sarcomatoid areas, dystrophic calcification and lacy malignant osteoid intermingled with malignant spindle cells (osteosarcoma component) were also noted ( Figure 4 ). Large areas of hemorrhage and coagulative necrosis were present. Epithelial tumor cells were immunoreactive for CK7 and E-cadherin and immunonegative for CD10 and Vimentin ( Figure 5 ). The sarcomatoid areas were immunopositive for Vimentin. There were perinephral tumor deposits, lymph node metastasis and perineural invasion. The final diagnosis was given as CRCC with sarcomatous differentiation containing osteosarcoma component. 
Discussion
Tryouts CRCC was first described by Thoenes et al. in 1985 (4) . It is a distinct subtype of RCC having good prognosis than the classical clear cell RCC (5) . CRCC arises from the intercalated cells of cortical segment of the collecting system. Therefore, these tumors have distinct morphological, histochemical and ultrastructural features along with unique molecular, genetic and clinical characteristics. Steffens S. et al. concluded that unlike conventional RCC, Fuhrman nuclear grading system for RCC is not applicable for prognosis in case of CRCC, as it showed inherent nuclear pleomorphism; therefore it was considered an inappropriate grading system for CRCC (6). Paner et al. gave a novel grading system based on nuclear crowding and anaplasia for CRCC (7 (8) . The sarcomatoid change in RCC can be seen in any subtypes (9, 10) . About 30 cases of sarcomatoid RCC with heterologous elements has been described in literature (11) . The sarcomatoid changes in RCC is the result of dedifferentiation of the parent tumor into high grade malignancy with poor prognosis (12) . The previous reports found that 5% of RCC have sarcomatoid differentiation and it is found most commonly associated with CRCC (9%) than conventional RCC (8%) and papillary RCC (3%) (10) . The sarcoma component of RCC generally consists of spindle cell sarcoma areas such as malignant fibrous histiocytoma or fibrosarcoma (8) . Presence of sarcomatoid area upgrades the tumor to World Health Organization/ International Society of Urological Pathology (WHO/ISUP) grade 4. The percentage of heterologous area varied between 5% to 70% in the whole tumor volume. Although heterologous differentiation in the form of osteosarcoma or rhabdomyosarcoma are seen very rarely (4,10). So far, 11 cases of sarcomatoid chromophobe RCC containing heterologous elements have been reported (3, 12, 13) . In chromophobe RCC, the presence of osteosarcoma in sarcomatoid component is documented in only five cases, two of which also showed chondrosarcomatous differentiation (7). Toshiki Hyodo et al. reported a case of chromophobe RCC with sarcomatoid differentiation that had multiple heterologous components including chondrosarcoma, osteosarcoma and a lipomatous area (13) .
The CRCC cases with sarcomatoid differentiation in the literature have shown distant organ metastases such as to the bone, liver, lung and lymph nodes. CRCC is mostly seen in stage T1 and T2; only 10% cases show extracapsular extension (1) . In the present case, CRCC showed sarcomatoid differentiation having heterologous component with perinephric fat involvement, perineural invasion and metastasis to periaortic lymph nodes, supporting the presence of a tumor progression pathway from chromophobe to sarcomatoid RCC. Rezakhaniha et al. found that CXCR3 is highly expressed in renal cancer cells as compared to the normal surrounding renal parenchyma. They also found that CXCR3 is well correlated with tumor metastasis and stages and CXCR2 is associated with high grade tumor, advance stages and tumor metastasis. And they concluded that overall overexpression of both chemokines are associated with poor prognosis (14) . Presence of only sarcomatoid cells in tumor are placed in the 'unclassified' category in the WHO classification. The closest differential of CRCC is renal oncocytoma and clear cell RCC with granular cytoplasm. Oncocytoma and CRCC both arise from intercalated cells and are usually confined to the kidney and show tan color. Central stellate scar can be seen in both oncocytoma (33%) and CRCC (15%). However, histomorphology of Clear cell RCC, oncocytoma and CRCC are different. In the present case, tumor cells are immunopositive for CK7 and immunonegative for CD10 and Vimentin and this ruled out the possibility of conventional clear cell RCC and oncocytoma.
Conclusion
CRCC containing osteosarcoma component, is very rare but its presence increases the aggressiveness and risk of metastasis. The correlation between the presence of heterologous elements and prognosis is unknown because of the rarity of this phenomenon. It is important to recognize this variant by extensive sampling.
